Abbott Laboratories (ABT)

EBITDA Growth

-2.46%

TTM · Period ending:

ABT logo

ABT EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-2.46%
ABT TTM EBITDA YoY % (18.91% → -2.46%)
High-resolution chart · PNG

ABT ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Abbott Laboratories EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
7.6146%
10.0613%
6.0374%
4.2268%
-2.9591%
-3.292%
2.1837%
3.5612%
8.6227%
10.0147%
9.0515%
9.3511%
8.796%
8.3792%
8.326%
8.6075%
9.6139%
10.3131%
11.9973%
13.9811%
13.8219%
12.459%
11.0979%
6.3091%
5.5484%
8.7652%
10.2433%
18.4987%
17.3038%
25.5938%
23.2431%
15.8876%
21.8752%
-0.0552%
0.9246%
3.3411%
-0.3855%
9.9063%
9.8689%
230.7184%
443.3259%
430.0994%
44.2925%
-203.031%
-141.3347%
-71.698%
10.8167%
-5.8554%
-4.63%
1.5794%
9.5754%
15.0753%
19.5274%
17.0518%
14.4662%
19.7657%
18.9054%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.